NUNNARI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 6.201
EU - Europa 4.622
AS - Asia 1.484
AF - Africa 7
SA - Sud America 7
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.328
Nazione #
US - Stati Uniti d'America 6.106
IE - Irlanda 1.855
SE - Svezia 1.072
CN - Cina 956
IT - Italia 760
PL - Polonia 465
SG - Singapore 351
FR - Francia 126
FI - Finlandia 95
CA - Canada 92
DE - Germania 86
VN - Vietnam 76
IN - India 67
GB - Regno Unito 42
UA - Ucraina 31
BE - Belgio 24
NL - Olanda 18
AT - Austria 13
KR - Corea 13
RU - Federazione Russa 13
CZ - Repubblica Ceca 12
TH - Thailandia 8
CH - Svizzera 6
AU - Australia 4
CL - Cile 3
JP - Giappone 3
NP - Nepal 3
ZA - Sudafrica 3
BG - Bulgaria 2
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GT - Guatemala 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TR - Turchia 1
UG - Uganda 1
VE - Venezuela 1
Totale 12.328
Città #
Dublin 1.855
Chandler 1.393
Nyköping 752
Warsaw 464
Princeton 440
Beijing 423
Dearborn 384
Jacksonville 318
Medford 306
Des Moines 251
Singapore 223
Ann Arbor 175
Boardman 167
Messina 165
Ashburn 158
Wilmington 128
Houston 86
New York 86
Ottawa 86
Dong Ket 74
Jinan 74
Cambridge 68
Shenyang 68
Nanjing 56
San Mateo 53
Falls Church 51
Seattle 51
Rome 49
Pune 48
Helsinki 46
Woodbridge 32
Los Angeles 31
Bremen 30
Norwalk 28
Tianjin 27
Zhengzhou 27
Milan 26
Redwood City 26
Guangzhou 25
Haikou 25
Brussels 24
Caltagirone 24
Hangzhou 24
Hebei 23
Taizhou 20
Catania 17
Nanchang 17
Philadelphia 17
Fairfield 16
Ningbo 15
Lanzhou 13
Brno 12
Changsha 12
Naples 12
Munich 11
Vienna 11
Fuzhou 10
Jiaxing 10
Mountain View 10
Bologna 9
Milazzo 9
Misterbianco 9
Palermo 9
Portici 9
West Lafayette 9
Bari 8
Belpasso 8
Kunming 8
Richmond 8
Sassari 8
Tappahannock 8
Yangcheon-gu 8
Borghetto Santo Spirito 7
Lancaster 7
Reggio Calabria 7
Amsterdam 6
Cagliari 6
Taiyuan 6
Clearwater 5
Florence 5
Hyderabad 5
St Louis 5
Castelbuono 4
Chiavari 4
Hefei 4
Imola 4
Paris 4
Seodaemun-gu 4
Sydney 4
Washington 4
Yantai 4
Zurich 4
Aci Bonaccorsi 3
Aci Catena 3
Almere Stad 3
Azzano San Paolo 3
Ban Kho 3
Barga 3
Cape Town 3
Cosenza 3
Totale 9.306
Nome #
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 398
MALATTIE INFETTIVE E TROPICALI PER STUDENTI E MEDICI DI MEDICINA GENERALE 142
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 129
Breast cancer in women living with HIV 113
Anal cancer in people living with HIV: the importance of the screening and of early diagnosis 101
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. 100
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals 94
Epidemiologia delle farmacoresistenze di HIV nella regione Sicilia 89
Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy 84
Sindrome di Castelman in paziente affetto da HIV e con sospetto Sarcoma di Kaposi. 84
Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily. 82
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudina/Dolutegravir Therapy in Human Immunodeficiency Virus Treatment-Experienced Patients. 81
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate 80
Contribution of naive CD4+T cells to the intact HIV reservoir 77
Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review 76
null 76
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 75
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 74
Circulating angiopoietin‑like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 73
Comparative neuropsychiatric toxicity profile of dolutegravir versus efavirenz versus other antiretroviral third drugs used either in first-line or switching antiretroviral therapies (ART): data from ICONA Foundation Study Cohort 73
Prostate cancer in HIV-positive patients: a review of the literature 72
Health status and Quality of life in people living with HIV (PLWH): results from the ICONA cohort 72
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 72
null 71
Tache Noire in a Patient with Acute Q Fever 70
Ocular surface manifestation of COVID-19 and tear film analysis 68
Anxiety disorders and adherence to HAART 67
Comparative neuropsychiatric toxicity profile of dolutegravir (DGT)-based versus efavirenz (EFV)-based versus other recommend first-line antiretroviral therapies (ART): data from ICONA Foundation Study Cohort. 67
Nail pigmentation and fatigue. 66
HIV and Colorectal Cancer. New Insights and Review of the Literature 64
HIV associated psoriasis: epidemiology, pathogenesis and management 64
Epidemiologia delle farmacoresistenza di HIV nella Regione Sicilia. 64
Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis 62
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project 61
Awareness and perception of accurancy of the Undetectable=Untransmittable (U=U) message in people living with HIV/AIDS (PLWHA), in Italy and correlation with the level of confidence in reference physicians. 61
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 61
Pityriasis rosea during etanercept therapy. 60
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? 59
The new era of vaccines: the “nanovaccinology” 58
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). 57
Transmission mode associated with coronavirus disease 2019: a review 55
HPV AND URINARY BLADDER CARCINOMA: A REVIEW OF THE LITERATURE 54
Effect of simplification to INSTI-based dual therapy on residual inflammation and viral reservoir 54
Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience 54
Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection 53
null 53
Malignant melanoma in HIV: epidemiology, pathogenesis and management 53
New and old assumptions of lung cancer in people living with HIV 53
Incidence and risk factors for liver enzyme elevation among naïve HIV-1 infected patients receiving ART in the ICONA cohort 52
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: Review of the literature and suggestions for a friendly use 52
ANAL CANCER IN HIV-POSITIVE PATIENTS 51
Achromobacter xylosoxidans meningitis in an immunosuppressed patient 50
Epatite A: immunità e accettazione della profilassi vaccinale in una coorte siciliana di pazienti con infezione da HIV. Dati preliminari. 50
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 50
THE UNDESIRED FELLOW TRAVELLER 49
HIV-RNA CD4/CD8 ratio and HDL concentration in a cohort of HIV + ART-naïve patients. 49
Impact of multi-drug resistance on mortality: a multi-cohort Italian study. 49
The role of the hospital environment in the healthcare-associated infections: a general review of the literature 48
Are HIV/HCV co.infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the ICONA Foundation Study. 48
Genetic evidence that Naïve T cells can contribute significantly to the HIV intact reservoir: time to re-evaluate their role 48
Cervical and lumbar diffuse Brucella spondylodiscitis: an uncommon case report 48
Cervical and lumbar diffuse Brucella spondylodiscitis: an uncommon case report 48
Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient 48
Factors Associated With Weight Gain in People Treated With Dolutegravir 48
Epidemiology of the new HIV infections in a large university hospital of Southern Italy: the importance of increasing the culture of the HIV screening test in the prevention of late diagnosis 48
Durability of F/TAF-based regimens in a large cohort of PLWH seen of care in Italy 48
Epstein Barr Virus related cancer in people living with HIV: a review of the literature 48
Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients 47
Acetyl-L-carnitine supplementation during HCV therapy with pegylated interferon-α 2b plus ribavirin: Effect on work performance; a randomized clinical trial 47
Is the rate of virological failure to cART continuing to decline in recent calendar years? 47
Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial 46
The Hepatitis C continuum of care among HIV infected individuals in the ICONA study network. 46
The treatment of Kaposi’s sarcoma: present and future options, a review of the literature 46
Bone safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-Word Cohort. 46
Definition of a novel vaccination pathway in PLWHA: experience of a Southern University Hospital 46
Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. 45
Pre-ART HIV-1 DNA in CD4! T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 45
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for HIV-infected people. 45
Incidence of dyslipidemia and modification of atherosclerotic cardiovascular disease (ASCVD) risk in HIV-infected patients who switch away from tenofovir disoproxil fumarato (TDF)-based to TDF-sparing regimens in the ICONA Foundation Cohort 45
Effectiveness of dolutegravir-based regimens as either first-line orswitch antiretroviral therapy: data from the Icona cohort 44
Persistence of an intact HIV reservoir in phenotypically naive T cells 44
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 44
Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: An update of new immune-modulating approaches 43
Tetanus immunity in construction workers in Italy 43
Acute non A-E hepatitis in eastern Sicily: the natural history and the role of hepatitis G virus. 43
CD4/CD8 ratio in patients who switch cART therapy: triple drug regimen could be better than mono/dual? 43
Trends and determinants of viral suppression among persons on HIV care in Italy. 43
Predictors of access and response to DAA in a cohort of human immunodeficincy virus/hepatitis C virus co-infected patients in Italy. 43
Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies 43
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives 42
Association between raised IL-8 serum levels and resistance to combined peg-interferon plus ribavirin therapy in HCV+ active chronic hepatitis. 42
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion 42
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients. 42
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 42
Un’epidemia di morbillo a catania, sicilia: l’importanza di un’elevata copertura vaccinale e della notifica precoce dei casi per ragioni sanitarie ed economiche 41
Still high risk of virus-related cancer despite 20 years of Cart in ICONA cohort. 41
CD4/CD8 ratio predicts the onset of virus-related cancers in HIV-positive patients on effective cART. 41
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study. 41
Silent COVID-19: what your skin can reveal 41
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives 41
Totale 6.198
Categoria #
all - tutte 66.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.447 0 0 0 16 41 449 120 114 115 340 169 83
2020/20211.852 63 80 384 147 404 117 136 112 104 126 71 108
2021/20222.129 36 147 28 88 132 48 164 110 66 105 273 932
2022/20235.640 718 348 191 478 404 516 101 331 2.290 29 168 66
2023/20241.231 153 209 111 102 81 215 35 54 9 36 20 206
2024/2025439 112 81 119 127 0 0 0 0 0 0 0 0
Totale 13.825